These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9167893)

  • 1. Small genetic effects in complex diseases: a review of regulatory sequence variants in dyslipoproteinemia and atherosclerosis.
    Hegele RA
    Clin Biochem; 1997 Apr; 30(3):183-8. PubMed ID: 9167893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins.
    Hegele RA; Connelly PW; Hanley AJ; Sun F; Harris SB; Zinman B
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2753-8. PubMed ID: 9409252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial disorders of plasma apolipoproteins.
    Sirtori CR; Franceschini G
    Klin Wochenschr; 1985 Jun; 63(11):481-9. PubMed ID: 3925218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory mutations in human lipoprotein disorders and atherosclerosis.
    Kontula K; Ehnholm C
    Curr Opin Lipidol; 1996 Apr; 7(2):64-8. PubMed ID: 8743897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the common apolipoprotein C-III (APOC3 -482C > T) and hepatic lipase (LIPC -514C > T) promoter variants affects glucose tolerance in young adults. European Atherosclerosis Research Study II (EARS-II).
    Jansen H; Waterworth DM; Nicaud V; Ehnholm C; Talmud PJ;
    Ann Hum Genet; 2001 May; 65(Pt 3):237-43. PubMed ID: 11427182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis.
    Tybjaerg-Hansen A; Nordestgaard BG; Gerdes LU; Faergeman O; Humphries SE
    Atherosclerosis; 1993 May; 100(2):157-69. PubMed ID: 8102848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of apolipoproteins on the anatomical distribution of arterial disease.
    Wiseman SA; Powell JT; Barber N; Humphries SE; Greenhalgh RM
    Atherosclerosis; 1991 Aug; 89(2-3):231-7. PubMed ID: 1686549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic high density lipoprotein deficiency states and atherosclerosis.
    Schaefer EJ; McNamara JR; Mitri CJ; Ordovas JM
    Adv Exp Med Biol; 1986; 201():1-15. PubMed ID: 3099550
    [No Abstract]   [Full Text] [Related]  

  • 10. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis.
    Horejsí B; Ceska R
    Physiol Res; 2000; 49 Suppl 1():S63-9. PubMed ID: 10984073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis.
    Vergnes L; Baroukh N; Ostos MA; Castro G; Duverger N; Nanjee MN; Najib J; Fruchart JC; Miller NE; Zakin MM; Ochoa A
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2267-74. PubMed ID: 11031214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of plasma lipoproteins with particular regard to hyperlipoproteinemias and atherosclerosis.
    Alaupovic P
    Ann Biol Clin (Paris); 1980; 38(2):83-93. PubMed ID: 6992659
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical disorders of lipoprotein metabolism.
    Brewer HB; Gregg RE; Hoeg JM; Law S
    Monogr Atheroscler; 1986; 14():159-68. PubMed ID: 3736557
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetics of lipoprotein disorders.
    Breslow JL
    Circulation; 1993 Apr; 87(4 Suppl):III16-21. PubMed ID: 8462176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lp(a) and the risk of coronary heart disease.
    Bihari-Varga M; Kostner G; Czinner A
    Eur J Epidemiol; 1992 May; 8 Suppl 1():33-5. PubMed ID: 1387093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Disorders of apolipoproteins and lipoprotein receptors].
    Itakura H; Matsumoto A
    Nihon Rinsho; 1990 Nov; 48(11):2666-74. PubMed ID: 2125327
    [No Abstract]   [Full Text] [Related]  

  • 17. [Apolipoproteinopathies].
    Assmann G
    Klin Wochenschr; 1983 Feb; 61(4):169-82. PubMed ID: 6405080
    [No Abstract]   [Full Text] [Related]  

  • 18. The genetic basis of lipoprotein disorders. Introduction and overview.
    Breslow JL
    J Intern Med; 1992 Jun; 231(6):627-31. PubMed ID: 1535651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial lipoprotein disorders in patients with premature coronary artery disease.
    Genest JJ; Martin-Munley SS; McNamara JR; Ordovas JM; Jenner J; Myers RH; Silberman SR; Wilson PW; Salem DN; Schaefer EJ
    Circulation; 1992 Jun; 85(6):2025-33. PubMed ID: 1534286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
    Yamashita S; Hirano K; Sakai N; Matsuzawa Y
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.